What the law does
Law No. 220 of 9 December 2021 prohibits financing companies, in Italy or abroad, that conduct specified activities involving anti-personnel mines, cluster munitions, submunitions, or parts of them. The prohibition can also reach activity conducted through controlled or associated companies under Article 2359 of the Italian Civil Code.
The law entered into force on 23 December 2021. The joint supervisory instrument is dated 23 July 2024, was published by Banca d’Italia on 26 July 2024, and was published in the Official Gazette on 7 August 2024. It entered into force the following day, and its six-month transition period has elapsed.
Who may be in scope
The law and final instructions address a broad group of authorized financial intermediaries and certain institutional investors. They include, among others, Italian banks, investment firms, asset managers, insurers, pension funds, banking foundations, and Italian branches of foreign intermediaries.
Direct regulatory scope
Confirm which legal entity, licensed activity, branch, and financing activity are subject to the Italian regime.
Delegated arrangements
An outsourced or delegated manager may receive screening instructions, but the supervised intermediary retains responsibility for its control framework.
A non-Italian manager may also encounter the rule through an Italian branch, a delegated mandate, a fund arrangement, or a client policy. Group-wide application should be an explicit legal and policy decision, not an assumption.
Activities and financing
The activity list is wider than manufacturing alone. A screen limited to companies labelled as weapon manufacturers can miss conduct named in the statute.
- Construction, production, development, and assembly
- Repair, conservation, use, storage, and possession
- Promotion, sale, distribution, import, and export
- Transfer and transport
- Specified technological research, manufacture, sale, transfer, import, export, and possession
- The covered weapons or parts of them, subject to treaty-based exceptions
“Financing” is deliberately broad
The statutory definition covers financial support provided in any form, including credit, guarantees, acquiring equity interests, and buying or subscribing for financial instruments issued by covered companies. The law also addresses financing through controlled entities.
The text contains treaty-based exceptions for activities expressly permitted by the Ottawa and Oslo Conventions. Those exceptions require case-specific legal analysis; they should not be approximated with a general revenue threshold.
Corporate relationships
Law 220/2021 expressly points to Article 2359 of the Civil Code. That legal cross-reference is more important than a generic ownership band.
| Relationship | Article 2359 signal | Screening implication |
|---|---|---|
| Controlled company | Majority voting rights, enough votes for dominant influence, or dominant influence through contractual relationships. | Record the actual control basis. A percentage alone may not settle the question. |
| Associated company | Significant influence; presumed at 20% of voting rights, or 10% where the company is listed. | Capture voting rights, listing status, influence evidence, date, and source. |
| Other group or holding | No automatic Article 2359 classification merely because an entity sits in the wider group or ownership chain. | Use as a risk indicator and investigate; do not silently convert it into a legal conclusion. |
Company Screener’s general 50% control and 20–<50% associated-company defaults are not a substitute for Article 2359. For this legal screen, the statutory control tests and listed-company 10% presumption need their own configuration.
What the final instructions require
The 2024 joint instructions expect documented controls that are risk-based and follow the principle of proportionality, rather than relying on a static exclusion list.
Check public lists and current evidence
The instructions require intermediaries to consult publicly available producer lists before financing. Reliable, current additional sources can supplement that check, particularly where a list is incomplete or unclear.
Match the whole relevant relationship
Do not check only the name in the portfolio. Check the actual issuer or recipient and the controlled or associated companies that may conduct the activity.
Investigate credible risk
If a company’s sector, products, location, or relationships raise a credible concern, gather more evidence rather than treating a missing list match as clearance.
Explain source conflicts
When sources disagree, record the conflict and why one source was considered more direct, current, or reliable. Keep both sources in the review history.
Make ownership of the control clear
Define who reviews matches, who approves decisions, who receives control reports, and who acts when a prohibited company or control failure is identified.
Check delegated managers
Give an external manager the rule and evidence expectations, receive enough reporting to test its work, and retain oversight of the resulting control.
A practical implementation model
In practice, the control begins with a holding or proposed transaction and ends with a documented decision, an investment action, and a route for later review.
- 01
Define the obligation
Identify which legal entity, fund, account, and delegated manager are covered. Write down which instruments and transactions the control applies to.
Example: an Italian-managed fund applies the Law 220 screen to direct corporate equity and debt before an order is released.
- 02
Match every holding
Connect each security or counterparty to the correct legal entity. Then map the controlled and associated companies that may bring it into scope.
Example: an ISIN resolves to the issuing subsidiary, which is linked to its listed parent and relevant operating companies.
- 03
Check before the decision
Check the matched entity against current public lists and reliable evidence before providing financing or approving an investment.
Example: a company that has not yet been evaluated is routed for review rather than treated as clear by default.
- 04
Prioritize higher-risk cases
Give faster or deeper review to companies whose products, sectors, locations, or corporate relationships create a credible connection to the covered activities.
Example: an aerospace and defence supplier with incomplete product disclosure receives enhanced review.
- 05
Gather enough evidence
Review company disclosures, official records, documented engagement, questionnaires, and traceable specialist research. Explain how conflicting sources were resolved.
Example: a company statement is compared with an official contract record; the decision notes which source is more specific and current.
- 06
Decide and apply the policy
Assign one of the two screening outcomes, record why, and apply the institution’s approved restriction or escalation procedure.
Example: “Involvement identified” blocks a new purchase and records the source, reviewer, relationship pathway, and policy action.
- 07
Recheck and report
Reopen the review when a list, source, company relationship, or methodology changes. Keep the earlier decision and report material issues through the control framework.
Example: a new subsidiary disclosure adds “Review required”; it does not silently overwrite the approved outcome.
A vendor list is an input, not the control. The defensible record includes list version, other sources, matching logic, relationship analysis, exceptions, rationale, reviewer, investment action, and later changes.
How Company Screener can support the control
Company Screener does not decide an institution’s legal obligations. It can make the screening control easier to apply, inspect, and evidence by connecting the portfolio, rule, corporate relationship, research, decision, and history.
Granular activity screens
Separate screens can address production, development, assembly, repair, storage, promotion, sale, distribution, transfer, transport, and parts. Clients can see exactly which activity triggered the result.
Entity and relationship context
The company under review can be connected to the legal entity conducting the activity, with the ownership pathway and supporting source shown alongside the result.
Source-backed decisions
Each company-screen result can preserve its evidence, rationale, review date, qualifiers, and the methodology version used.
Audit history
Re-evaluations, evidence suggestions, reviewer actions, policy changes, and superseded outcomes remain retraceable instead of replacing the prior record.
Portfolio and watchlist review
Clients can upload holdings or create focused watchlists, select the relevant screens, and review which companies have or have not had involvement identified.
Corrections and re-evaluation
Authorized users can submit evidence, request a re-evaluation, or do both through a moderated workflow that preserves the history.
Add an “Article 2359 relationship review” flag
A single 10% hierarchy cutoff would be too blunt. The proposed flag should trigger at 10% of voting rights for a listed company, 20% for an unlisted company, or at any percentage when evidence indicates contractual or practical control. Missing or conflicting ownership evidence should also trigger review.
Relationship path, voting rights, listing status, control basis, source, and date
Route the corporate relationship to review before relying on the activity result
Treat the flag itself as “Involvement identified” or as a legal conclusion
Publish a sourced company-screen index when research coverage is ready
The useful public product is not an unexplained blacklist. Each company entry should show the specific activity screen, entity and ownership pathway, outcome, evidence, last-reviewed date, methodology version, and correction route. Historical versions should remain available when an assessment changes.
Practical default and conservative overlay
A useful policy distinguishes the supportable legal screen from choices made to reduce uncertainty or reputational risk. The conservative option below is a policy overlay, not a claim that every item is legally required.
| Dimension | Practical defaultRecommended starting point | Conservative overlayOptional risk treatment |
|---|---|---|
| Weapon scope | Apply the statutory anti-personnel mine, cluster munition, submunition, and parts scope. Maintain broader weapon exclusions as separate policy rules. | Add other controversial weapons as a house-policy overlay, clearly labelled as policy rather than Law 220/2021. |
| Components and services | Identify parts where evidence links the product to a covered weapon or prohibited activity. Record the factual connection. | Also investigate dedicated delivery platforms, integral services, and enabling technology where the connection is credible but the legal treatment is uncertain. |
| Corporate reach | Apply the relationships referenced by Article 2359, including control and significant influence, with evidence for the applicable pathway. | Look further across the group and other influential holdings as a risk screen, without automatically labelling every related entity a statutory match. |
| Revenue threshold | Do not add a de minimis revenue threshold to the legal screen: the statutory text states a total ban and does not provide one. | Use zero tolerance for credible covered involvement and a wider watchlist for unresolved indicators. |
| Uncertain evidence | Preserve the latest supported outcome with an evidence qualifier and require review before relying on it. | Place the issuer on a temporary restricted or watch status while enhanced review is completed. |
A broader policy can be sensible, but it should produce a separate policy result. This avoids representing a house view about delivery systems, services, or other weapon types as a statutory Law 220/2021 determination.
Evidence and decision design
The screening result should remain binary. Uncertainty belongs in workflow state and evidence qualifiers, not in extra outcomes that blur what was decided.
Involvement identified
The available evidence supports that the entity meets the configured Law 220/2021 screening rule.
No involvement identified
A completed review did not identify evidence meeting the configured rule. This is not a universal claim of absence.
Not yet evaluated
A neutral placeholder until either outcome is assigned. Evidence incomplete, conflicting, stale, and review required are qualifiers that explain the record; they are not additional outcomes.
Minimum decision record
- Legal entity and instrument identifiers
- Applicable rule and policy version
- Direct, controlled, or associated pathway
- Voting rights, listing status, and control evidence
- Activity and weapon or component connection
- Sources, publication dates, and retrieval dates
- Conflicts, gaps, and reason for source selection
- Outcome, qualifiers, rationale, reviewer, and action
- List version, monitoring event, and superseded record
- Mandate, account, or portfolio scope
Sources and limits
This public source list is limited to the official law, official supervisory material, and an English-language humanitarian-law reference. The Italian sources control.
An exclusion list without definitions, source lineage, relationship logic, versioning, and review history is not enough to reproduce a compliance decision.